Mitoxantrone
FDA Approved: * April 11, 2006Pharm Company: * BEDFORD
Category: Cancer
Mitoxantrone (INN, BAN, USAN; also known as Mitozantrone in Australia; trade name Novantrone) is an anthracenedione antineoplastic agent. Contents 1 Uses 2 Side effects 3 Mechanism of action 4 See also 5 References 6 External links Uses Mitoxantrone is used to treat certain types of cancer, mostly acute myeloid leukemia. It improves the survival rate of children suffering from acute lymphoblastic leukemia relapse.[1] The combination of mitoxantrone and prednisone is app... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.Dosage List
Mitoxantrone Hydrochloride 2 mg/ml Intravenous Injection, Solution
NDC: 0069-0080
Labeler:
Pfizer Laboratories Div Pfizer Inc.
Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0703-4680
Labeler:
Teva Parenteral Medicines, Inc
Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0703-4685
Labeler:
Teva Parenteral Medicines, Inc
Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 0703-4686
Labeler:
Teva Parenteral Medicines, Inc
Mitoxantrone 2 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 61703-343
Labeler:
Hospira Worldwide, Inc.
Mitoxantrone 2 mg/ml Intravenous Injection, Solution
NDC: 63323-132
Labeler:
App Pharmaceuticals, LLC
Related Brands
Drugs with the same active ingredients